Gene · 2280
Papers1,820
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,820
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CHKB-AS1 enhances proliferation and resistance to NVP-BEZ235 of renal cancer cells via regulating the phosphorylation of MAP4 and PI3K/AKT/mTOR signaling. | Eur J Med Res | 2023 | 38093375 | PubTator, text mining | PubMed |
| Population pharmacokinetics of everolimus in patients with seizures associated with focal cortical dysplasia. | Front Pharmacol | 2023 | 38074125 | PubTator, text mining | PubMed |
| Multi-level characteristics recognition of cancer core therapeutic targets and drug screening for a broader patient population. | Front Pharmacol | 2023 | 38074121 | PubTator, text mining | PubMed |
| Harnessing PROTAC technology to combat stress hormone receptor activation. | Nat Commun | 2023 | 38071198 | PubTator, text mining | PubMed |
| FK506 bypasses the effect of erythroferrone in cancer cachexia skeletal muscle atrophy. | Cell Rep Med | 2023 | 38052214 | PubTator, text mining | PubMed |
| New insights into the stemness of adoptively transferred T cells by γc family cytokines. | Cell Commun Signal | 2023 | 38049832 | PubTator, text mining | PubMed |
| Identification of a Novel CD8+ T cell exhaustion-related gene signature for predicting survival in hepatocellular carcinoma. | BMC Cancer | 2023 | 38049741 | PubTator, text mining | PubMed |
| Ubiquitin-specific protease 22 promotes tumorigenesis and progression by an FKBP12/mTORC1/autophagy positive feedback loop in hepatocellular carcinoma. | MedComm (2020) | 2023 | 38045832 | PubTator, text mining | PubMed |
| Neuroprotective Action of Tacrolimus before and after Onset of Neonatal Hypoxic-Ischaemic Brain Injury in Rats. | Cells | 2023 | 37998394 | PubTator, text mining | PubMed |
| Using Drosophila melanogaster to Dissect the Roles of the mTOR Signaling Pathway in Cell Growth. | Cells | 2023 | 37998357 | PubTator, text mining | PubMed |
| Examination of newborn DNA methylation among women with polycystic ovary syndrome/hirsutism. | Epigenetics | 2023 | 37992405 | PubTator, text mining | PubMed |
| Leveraging diverse cell-death patterns to predict the prognosis, immunotherapy and drug sensitivity of clear cell renal cell carcinoma. | Sci Rep | 2023 | 37985807 | PubTator, text mining | PubMed |
| Aberrant mitochondrial dynamics contributes to diaphragmatic weakness induced by mechanical ventilation. | PNAS Nexus | 2023 | 37954156 | PubTator, text mining | PubMed |
| A phosphoinositide switch mediates exocyst recruitment to multivesicular endosomes for exosome secretion. | Nat Commun | 2023 | 37898620 | PubTator, text mining | PubMed |
| TACkling Cancer by Targeting Selective Protein Degradation. | Pharmaceutics | 2023 | 37896202 | PubTator, text mining | PubMed |
| Safety and Efficacy of an Innovative Everolimus-Coated Balloon in a Swine Coronary Artery Model. | Life (Basel) | 2023 | 37895434 | PubTator, text mining | PubMed |
| Meibomian Gland Dysfunction Is Associated with Low Levels of Immunoglobulin Chains and Cystatin-SN. | Int J Mol Sci | 2023 | 37894795 | PubTator, text mining | PubMed |
| Microsponge-derived mini tablets loaded with immunosuppressive agents: Pharmacokinetic investigation in human volunteers, cell viability and IVIVC correlation. | Saudi Pharm J | 2023 | 37868642 | PubTator, text mining | PubMed |
| Sympathetic activity regulates epithelial proliferation and wound healing via adrenergic receptor α2A. | Sci Rep | 2023 | 37863979 | PubTator, text mining | PubMed |
| Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment. | Int J Mol Sci | 2023 | 37834408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2280/papers?page=5